Rituximab and its use in autoimmune bullous disorders

Immunology and Allergy Clinics of North America
Benjamin S DanielPascal Joly

Abstract

Rituximab is a chimeric, murine-human, monoclonal antibody against the CD20 antigen of B lymphocytes. It has been used off-label to treat and manage autoimmune and dermatologic diseases as an alternative or adjuvant therapy to systemic treatments. Due to cost, potential complications, and lack of data rituximab is used after standard systemic therapies have failed or the patient is absolutely contraindicated for corticosteroids. More research is required.

References

Mar 1, 1997·Archives of Dermatology·J M AzañaA España
Feb 1, 2002·The New England Journal of Medicine·Pascal JolyUNKNOWN Bullous Diseases French Study Group
Jan 21, 2004·Archives of Dermatology·Alain DupuyHervé Bachelez
Apr 20, 2006·Nature Reviews. Immunology·Jonathan C W Edwards, Geraldine Cambridge
May 24, 2006·Clinical and Experimental Dermatology·E SchmidtM Goebeler
Oct 27, 2006·The New England Journal of Medicine·A Razzaque AhmedMarshall R Posner
Jan 17, 2007·The British Journal of Dermatology·E SchmidtM Goebeler
Jun 29, 2007·The British Journal of Dermatology·E SadlerJ W Bauer
Aug 10, 2007·The New England Journal of Medicine·Pascal JolyPhilippe Musette
Feb 22, 2008·International Journal of Dermatology·Annesofie Faurschou, Robert Gniadecki
Mar 8, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Z SaouliZ Kontoninas
Jun 20, 2008·The Journal of Investigative Dermatology·Hugo MouquetPascal Joly
Jun 20, 2008·The Journal of Investigative Dermatology·Rüdiger EmingMichael Hertl
Sep 16, 2008·Pediatric Dermatology·Johannes SchulzeStefan Zielen
Nov 11, 2008·The Journal of Investigative Dermatology·Giovanna Zambruno, Luca Borradori
May 27, 2009·British Journal of Haematology·Vickie McDonald, Maria Leandro
Apr 10, 2010·Drug Discovery Today. Therapeutic Strategies·Iñaki Sanz
Jun 1, 2010·Dermatologic Clinics·David R Carr, Michael P Heffernan
Nov 9, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·S LourariC Paul
Mar 23, 2011·Archives of Dermatology·Christelle Le Roux-VilletHervé Bachelez
Jul 6, 2011·Indian Journal of Dermatology, Venereology and Leprology·Sanjay Singh

❮ Previous
Next ❯

Citations

Nov 27, 2015·Pediatric Dermatology·Fernanda Bellodi-Schmidt, Kara N Shah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

Related Papers

Dermatologic Clinics
Benjamin S DanielPascal Joly
Current Opinion in Allergy and Clinical Immunology
Martin Metz, Marcus Maurer
The Journal of Dermatological Treatment
Vincenzo BettoliAnna Virgili
© 2021 Meta ULC. All rights reserved